| Literature DB >> 28930170 |
Xue Dong Chen1, Lukasz L Stelinski2.
Abstract
The Asian citrus psyllid, Diaphorina citri Kuwayma, is one of the most important pests in citrus production. The objective of this study was to evaluate D. citri resistance management with three insecticide rotations and compare them with no rotation and an untreated check. The different insecticides (modes of action) tested were: dimethoate, imidacloprid, diflubenzuron, abamectin 3% + thiamethoxam 13.9%, and fenpropathrin. Eggs, nymph, and adult psyllids were counted weekly. Five insecticide applications were made in 2016. Insecticide susceptibility was determined by direct comparison with a laboratory susceptible population and field populations before and after all treatments were applied. Rankings of eggs, nymphs, and adults counted in treated plots were significantly lower than in the untreated control plots after each application. Initially, the resistance ratio (RR50) for each rotation model, as compared with laboratory susceptible strain and the field population before application, was less than 5.76 and 4.31, respectively. However, after five applications with dimethoate, the RR50 using the laboratory and pre-treatment field populations was 42.34 and 34.74, respectively. Our results indicate that effectively rotating modes of action can delay and/or prevent development of insecticide resistance in populations of D. citri.Entities:
Keywords: insecticide resistance; leaf dip bioassay; mode of action; resistance management strategy; rotational model
Year: 2017 PMID: 28930170 PMCID: PMC5620723 DOI: 10.3390/insects8030103
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 2.769
Formulated insecticides evaluated as part of rotation modules for management of Asian citrus psyllid, Diaphorina citri.
| TRADE NAME | Active Ingredients | IRAC a | Rate/Acre (lb) | Chemical Class | MOA b | Manufacturer |
|---|---|---|---|---|---|---|
| Dimethoate 4E | Dimethoate (43.5%) | 1B | 1.0 | Organophosphate | AChE inhibitor | Cheminova |
| Admire Pro 4.6F | Imidacloprid (42.8%) | 4A | 0.5 | Neonicotinoid | nAChR competitive modulator | Bayer Crop Science |
| Micromite 80WGS c | Diflubenzuron (80%) | 15 | 0.39 | Insect growth regulator | Inhibitor of chitin biosynthesis | Chemtura |
| Agri-Flex c | Abamectin 3% + Thiamethoxam 13.9% | 6 + 4A | 0.53 | Microbial + Neonicotinoid | GluCl allosteric + nAChR competitive modulator | Syngenta Crop Protection |
| Danitol 2.4EC | Fenpropathrin (30.9%) | 3A | 0.40 | Pyrethroid | Sodium channel modulator | Valent Inc. |
a IRAC: Insecticide Resistance Action Committee (IRAC) classification; b MOA = mode of action; AChE: Acetylcholinesterase; nAChR: Nicotinic acetylcholine receptor; GluCI: Glutamate gated chloride channels; c with IAP 435 CROP oil 0.2% v/v.
Rotation schedule treatments and dates of application.
| Treatment | Date of Application | ||||
|---|---|---|---|---|---|
| 24 May 2016 | 23 June 2016 | 27 July 2016 | 7 September 2016 | 5 October 2016 | |
| dimethoate | abamectin + thiamethoxam | fenpropathrin | diflubenzuron | imidacloprid | |
| imidacloprid | fenpropathrin | abamectin + thiamethoxam | dimethoate | diflubenzuron | |
| abamectin + thiamethoxam | diflubenzuron | dimethoate | imidacloprid | fenpropathrin | |
| dimethoate | dimethoate | dimethoate | dimethoate | dimethoate | |
| - | - | - | - | - | |
Average density rankings (±SE) of Asian citrus psyllid, Diaphorina citri, egg, nymph, and adult counts upon plot establishment and immediately prior to first treatment application.
| Rotation Program | 17 March 2016 a | 19 May 2016 b | ||||
|---|---|---|---|---|---|---|
| Egg | Nymph | Adult | Egg | Nymph | Adult | |
| 0.05 ± 0.05 | 0.03 ± 0.02 | 0.00 ± 0.00 | 1.10 ± 0.21 | 1.81 ± 0.20 | 1.50 ± 0.27 | |
| 0.08 ± 0.04 | 0.27 ± 0.07 | 0.05 ± 0.04 | 1.43 ± 0.16 | 2.43 ± 0.17 | 1.18 ± 0.28 | |
| 0.10 ± 0.05 | 0.33 ± 0.11 | 0.08 ± 0.04 | 1.24 ± 0.18 | 2.15 ± 0.19 | 1.03 ± 0.20 | |
| 0.03 ± 0.03 | 0.11 ± 0.07 | 0.05 ± 0.05 | 1.69 ± 0.18 | 2.51 ± 0.13 | 1.25 ± 0.28 | |
| 0.28 ± 0.16 | 0.67 ± 0.13 | 0.00 ± 0.00 | 1.06 ± 0.20 | 1.61 ± 0.23 | 1.64 ± 0.30 | |
a Monitoring initiated; b Above threshold prior to first application.
Average density ranking (±SE) of Asian citrus psyllid, Diaphorina citri, egg, nymph, and adult counts during rotation treatments (31 May 2016 to 26 October 2016).
| Rotation Program | Egg (Mean ± SE) | Nymph (Mean ± SE) | Adult (Mean ± SE) |
|---|---|---|---|
| 0.69 ± 0.03a | 0.89 ± 0.04a | 0.19 ± 0.03a | |
| 0.73 ± 0.03a | 1.02 ± 0.04a | 0.31 ± 0.03a | |
| 0.73 ± 0.03a | 1.05 ± 0.04a | 0.13 ± 0.03a | |
| 0.62 ± 0.03a | 1.23 ± 0.04b | 0.23 ± 0.03a | |
| 0.97 ± 0.03b | 1.67 ± 0.04c | 0.83 ± 0.03b |
Mean number of eggs, nymphs, and adults followed by same letter in the columns are not significant (Bonferroni test; p < 0.05).
Susceptibility of Diaphorina citri adults exposed to fenpropathrin from field plots under different treatment rotations.
| Population | N | χ2 | Slope ± SE | LC50 (ng/µL) a 95% FL | LC95(ng/µL) (95% FL) b | L-RR50 | F-RR50 | L-RR95 | F-RR95 |
|---|---|---|---|---|---|---|---|---|---|
| 350 | 4.55 | 1.20 ± 0.13 | 0.15 (0.09–0.23) | 3.42 (1.70–9.3) | 1 | 1 | |||
| 300 | 6.01 | 0.87 ± 0.10 | 0.16 (0.09–0.27) | 12.14 (5.13–43.03) | 1.07 | 1 | 3.55 | 1 | |
| 288 | 96 | 1.00 ± 0.16 | 0.31 (0.09–1.15) | 13.44 (2.8–584.2) | 2.07 | 1.93 | 3.93 | 1.11 | |
| 292 | 8.06 | 0.93 ± 0.14 | 0.23 (0.07–0.78) | 13.28 (2.8–363.6) | 1.53 | 1.43 | 3.88 | 1.09 | |
| 289 | 3.84 | 1.14 ± 0.13 | 0.22 (0.13–0.36) | 6.09 (2.86–18.52) | 1.47 | 1.38 | 1.78 | 0.50 | |
| 292 | 9.09 | 0.93 ± 0.14 | 0.24 (0.07–0.80) | 13.59 (2.9–360.4) | 1.60 | 1.50 | 4.00 | 1.12 | |
| 293 | 6.42 | 1.06 ± 0.12 | 0.23 (0.14–0.38) | 8.08 (3.67–25.39) | 1.53 | 1.44 | 2.36 | 0.67 |
a L-RR50 and L-RR95 = Field LC50 or Field LC95/Lab LC50 or Lab LC95; F-RR50 or F-RR95 = after application LC50 or LC95/before application LC50 or LC95; b FL = Fiducial Limits.
Susceptibility of Diaphorina citri adults exposed to abamectin 3% + thiamethoxam 13.9% from field plots under different treatment rotations.
| Population | N | χ2 | Slope ± SE | LC50 (ng/µL) a 95% FL | LC95(ng/µL) (95% FL) b | L-RR50 | F-RR50 | L-RR95 | F-RR95 |
|---|---|---|---|---|---|---|---|---|---|
| 300 | 1.11 | 0.76 ± 0.09 | 0.09 (0.05–0.17) | 13.64 (2.28–56.84) | 1 | 1 | |||
| 350 | 1.77 | 0.74 ± 0.13 | 0.12 (0.06–0.22) | 19.41 (7.62–75.97) | 1.33 | 1 | 1.42 | 1 | |
| 285 | 5.70 | 0.90 ± 0.10 | 0.04 (0.02–0.07) | 2.83 (1.16–10.47) | 0.44 | 0.33 | 0.21 | 0.15 | |
| 281 | 7.33 | 0.79 ± 0.09 | 0.05 (0.01–0.16) | 4.65 (1.72–20.06) | 0.56 | 0.42 | 0.34 | 0.24 | |
| 284 | 2.49 | 0.87 ± 0.10 | 0.04 (0.02–0.07) | 2.78 (1.11–10.65) | 0.44 | 0.33 | 0.20 | 0.14 | |
| 283 | 2.91 | 0.95 ± 0.11 | 0.05 (0.03–0.08) | 2.37 (1.01–8.20) | 0.56 | 0.42 | 0.17 | 0.12 | |
| 283 | 8.85 | 0.96 ± 0.16 | 0.07 (0.02–0.26) | 3.76 (0.78–135.1) | 0.78 | 0.58 | 0.27 | 0.19 |
a L-RR50 and L-RR95 = Field LC50 or Field LC95/Lab LC50 or Lab LC95; F-RR50 or F-RR95 = after application LC50 or LC95/before application LC50 or LC95; b FL = Fiducial Limits.
Susceptibility of Diaphorina citri adults exposed to dimethoate from field plots under different treatment rotations.
| Population | N | χ2 | Slope ± SE | LC50 (ng/µL) a 95% FL | LC95(ng/µL) (95% FL) b | L-RR50 | F-RR50 | L-RR95 | F-RR95 |
|---|---|---|---|---|---|---|---|---|---|
| 300 | 5.81 | 1.04 ± 0.11 | 0.32 | 11.80 | 1 | 1 | |||
| 300 | 5.92 | 1.14 ± 0.12 | 0.39 | 10.51 | 1.22 | 1 | 0.89 | 1 | |
| 277 | 7.49 | 0.81 ± 0.09 | 1.68 | 172.92 | 5.25 | 4.31 | 14.65 | 16.5 | |
| 283 | 13.81 | 0.93 ± 0.18 | 0.39 | 23.20 | 1.22 | 1 | 1.97 | 2.21 | |
| 277 | 19.47 | 0.90 ± 0.21 | 1.20 | 79.98 | 3.75 | 3.08 | 6.78 | 7.61 | |
| 283 | 14.73 | 0.56 ± 0.14 | 13.55 | 11,126 | 42.34 | 34.74 | 952.88 | 1058 | |
| 290 | 4.30 | 0.75 ± 0.08 | 0.48 | 73.69 | 1.5 | 1.23 | 6.25 | 7.01 |
a L-RR50 and L-RR95 = Field LC50 or Field LC95/Lab LC50 or Lab LC95; F-RR50 or F-RR95 = after application LC50 or LC95/before application LC50 or LC95; b FL = Fiducial Limits.
Susceptibility of Diaphorina citri adults exposed to imidacloprid from field plots under different treatment rotations.
| Population | N | χ2 | Slope ± SE | LC50 (ng/µL) a 95% FL | LC95(ng/µL) (95% FL) b | L-RR50 | F-RR50 | L-RR95 | F-RR95 |
|---|---|---|---|---|---|---|---|---|---|
| 350 | 9.42 | 0.32 ± 0.14 | 0.33 | 95.01 | 1 | 1 | |||
| 350 | 9.04 | 0.10 ± 0.15 | 0.75 | 385.98 | 2.27 | 1 | 4.06 | 1 | |
| 280 | 1.31 | 0.44 ± 0.06 | 1.90 | 10,390 | 5.76 | 2.53 | 109.3 | 26.92 | |
| 281 | 1.99 | 0.57 ± 0.06 | 0.71 | 576.40 | 2.15 | 0.94 | 6.06 | 1.49 | |
| 280 | 1.69 | 0.56 ± 0.07 | 1.17 | 1024 | 3.54 | 1.56 | 10.77 | 2.65 | |
| 280 | 1.70 | 0.46 ± 0.06 | 1.63 | 5664 | 4.94 | 2.17 | 59.61 | 14.67 | |
| 280 | 3.62 | 0.54 ± 0.06 | 0.81 | 878.77 | 2.46 | 1.08 | 9.24 | 2.28 |
a L-RR50 and L-RR95 = Field LC50 or Field LC95/Lab LC50 or Lab LC95; F-RR50 or F-RR95 = after application LC50 or LC95/before application LC50 or LC95; b FL = Fiducial Limits.